Page 2 - Eris Lifesciences

Eris Lifesciences hits record low as stock turns ex-date for share buyback

On July 3, the company's board approved buyback of shares worth up to Rs 100 crore. The buyback is for 1.74 million shares at Rs 575 per share.

From Linedex to UTH: Eris' acquired portfolio moving in a slow lane

After growing organically for almost a decade, Eris had made four acquisitions of distressed businesses in a couple of years

Eris Lifesciences trades higher for fifth straight trading day

Stock of the pharmaceutical company outperformed the market by gaining 12% in past five trading days, as compared to 1.3% decline in the S&P BSE Sensex.

Eris Life extends rally post acquisition of Strides' India branded business

The stock rallied 11% to Rs 721, extending its 11% gain in past six trading sessions.

Eris Lifesciences eyes high-margin segments

In 2016, Eris acquired 75.48% in Kinedex, for an aggregate consideration of Rs 77.18 crore

Eris Lifesciences acquires UTH Healthcare for Rs 12.85 crore

This is the company's first acquisition after being listed on the exchanges earlier this year

Eris Lifesciences makes quiet debut, ends below IPO price

The stock slipped to Rs 592, 2% below its IPO price of Rs 603, after listing at Rs 612 on the BSE

Eris Lifesciences: Costly prescription

Segments it operates in offer scope for growth but valuations too expensive for comfort